Advanced Cooling Therapy plans full commercial launch after closing its $1.5 million funding round.
Chicago-based Advanced Cooling Therapy is planning to break onto the market now that it's closed a $1.5 million Series A funding round.
ACT is building up to full commercial launch of its Esophageal Cooling Device, which has approval from European and Canadian regulators. The device is not yet cleared for the U.S.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1mQSrFb
Cap comentari:
Publica un comentari a l'entrada